Pamela Esposito's Net Worth
$10.4 Million
Who is Pamela Esposito?
Pamela Esposito has an estimated net worth of $10.4 Million. This is based on reported shares across multiple companies, which include Replimune Group, Inc., and Kymera Therapeutics, Inc..
SEC CIK
Pamela Esposito's CIK is 0001744425
Past Insider Trading and Trends
2021 was Pamela Esposito's most active year for acquiring shares with 14 total transactions. Pamela Esposito's most active month to acquire stocks was the month of March. 2021 was Pamela Esposito's most active year for disposing of shares, totalling 24 transactions. Pamela Esposito's most active month to dispose stocks was the month of December. 2021 saw Pamela Esposito paying a total of $598,320.00 for 267,478 shares, this is the most they've acquired in one year. In 2021 Pamela Esposito cashed out on 324,000 shares for a total of $6,621,085.76, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Replimune Group, Inc. (REPL) Snapshot price: $10.88
Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$11.66 | -$94,542.18 | 263.44K |
Sep 11 - Sep 12
| |||
Form 4
|
—
|
0
|
$13.30 | -$249,806.00 | 263.44K |
Aug 22
| |||
Form 4
|
—
|
0
|
$11.65 | -$23,380.00 | 263.44K |
Aug 11
| |||
Form 4
|
—
|
0
|
$13.97 | -$304,540.73 | 263.44K |
Jul 10
| |||
Form 4
| -2.21% | -5.97K |
$18.05 | -$107,686.30 | 263.44K |
May 16
| |||
Form 4
| +17.44% | 40K |
—
|
—
| 269.4K |
Apr 1
| |||
Form 4
|
—
|
0
|
$13.02 | -$360,300.00 | 229.4K |
Scheduled
|
Dec 9
| ||
Form 4
| -1.51% | -3.51K |
$14.59 | -$51,167.13 | 229.4K |
May 16
| |||
Form 4
| +10.83% | 22.75K |
—
|
—
| 232.91K |
Apr 1
| |||
Form 4
|
—
|
0
|
$25.29 | -$587,322.00 | 210.16K |
Scheduled
|
Aug 4 - Aug 5
| ||
Form 4
|
—
|
0
|
$17.08 | -$559,000.56 | 210.16K |
Scheduled
|
Jul 20 - Jul 21
| ||
Form 4
|
—
|
0
|
$17.19 | -$148,856.00 | 210.16K |
Scheduled
|
Jul 15
| ||
Form 4/A
|
—
|
0
|
$22.50 | -$2,363,793.60 | 175.99K |
Scheduled
|
Jan 14 - Jan 19
| ||
Form 4
| +19.41% | 34.16K |
—
|
—
| 210.16K |
Apr 1
| |||
Form 4
|
—
|
0
|
$22.50 | -$2,363,793.60 | 175.99K |
Scheduled
|
Jan 14 - Jan 19
| ||
Form 4
| +40.47% | 50.7K |
$1.75 | $88,732.00 | 175.99K |
Dec 23
| |||
Form 4
| +11.17% | 12.59K |
$3.30 | $41,547.00 | 125.29K |
Dec 11
| |||
Form 4
|
—
|
0
|
$16.95 | -$510,250.00 | 112.7K |
Scheduled
|
Oct 14
| ||
Form 4
|
—
|
0
|
$14.03 | -$130,200.00 | 112.7K |
Scheduled
|
Aug 31
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
| +29.54% | 25.7K |
$1.75 | $44,975.00 | 112.7K |
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
∞
| 87K |
$1.75 | $152,250.00 | 87K |
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kymera Therapeutics, Inc. (KYMR) Snapshot price: $45.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$36.07 | -$329,690.65 |
0
|
Sep 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||